Enteral composition for the prevention and/or treatment of sepis
AssigneeN.V. Nutricia
InventorsGelske Speelmans, Adrianus Vriesema, Anita Vreugdenhil, Willem Buurman, Johannes Greve, Zandrie Hofman, Inge Kivit, Robert Hageman
Life of this patent
Estimating the term…
Abstract
Enteral compositions and use thereof, which compositions contain proteins and lipids, for the prevention and/or treatment of sepsis; the lipid fraction being particularly rich in phospholipids.
Claims24
1-24. (canceled)
A method for the treatment and/or prevention of endotoxaemia, sepsis, or bacteraemia, the method of comprising administering enterally to a mammal in need thereof a composition comprising proteins and lipids, the lipids comprising phospholipids and triglycerides in a weight ratio of phospholipids to triglycerides greater than 1, and wherein the composition comprises less than 0.5% by weight of cholesterol or precursors thereof.
An enteral composition comprising:
- a)—at least 1% by weight of proteins and/or peptides, and
- b)—at least 3.5% by weight of lipids, the lipid fraction comprising phospholipids and triglycerides in a weight ratio of phospholipids to triglycerides greater than 1, and wherein the composition comprises less than 0.5% by weight of cholesterol or precursors thereof, wherein said phospholipids are present in an amount of at most 78 wt % of the lipid fraction, and wherein the triglycerides contain at least 50 wt % long chain fatty acids.
Dependencies are inferred from the claim text.